PetVivo Holdings PETV
OTC PETV
$0.52 +0.05 (+10.64%)
At close: Nov 13, 2026 · 4:00 PM EST

PetVivo Holdings (PETV) Gains from Sales and Divestitures (2019 - 2025)

Updated

PetVivo Holdings' Gains from Sales and Divestitures was -$149,125 in FY2026 (year ended Mar 31, 2026).

Analysis

PetVivo Holdings (PETV) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends

  • The FY2026 figure marks the highest annual Gains from Sales and Divestitures since FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 PetVivo Holdings 19.55 Mn 18.29 Mn 223,317.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -149,125.00
Jun 30, 2020 482.00
Mar 31, 2020 -839.00
Jun 30, 2019 450.00
API Access

PetVivo Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PETV&period=max&api_key=YOUR_API_KEY